Agfa lands huge Australian PACS deal
PACS firm Agfa has received a $25 million contract from Queensland Health of Australia, which will use the Ridgefield Park, NJ-based firm’s Impax PACS offering to link the imaging units at five tertiary teaching hospitals. Impax software,
PACS firm Agfa has received a $25 million contract from Queensland Health of Australia, which will use the Ridgefield Park, NJ-based firms Impax PACS offering to link the imaging units at five tertiary teaching hospitals. Impax software, workstations, and other hardware for electronic image capture, transmission, display, and archiving will be provided to the Royal Brisbane, Royal Womens, Royal Childrens, Princess Alexandra, and Townsville General hospitals. Agfa will also serve as a systems integrator, linking Impax with four other major digital technology suppliers. Queensland Health hopes to convert to a totally filmless environment within two to three years, according to Agfa.
Considering Breast- and Lesion-Level Assessments with Mammography AI: What New Research Reveals
June 27th 2025While there was a decline of AUC for mammography AI software from breast-level assessments to lesion-level evaluation, the authors of a new study, involving 1,200 women, found that AI offered over a seven percent higher AUC for lesion-level interpretation in comparison to unassisted expert readers.
SNMMI: Can 18F-Fluciclovine PET/CT Bolster Detection of PCa Recurrence in the Prostate Bed?
June 24th 2025In an ongoing prospective study of patients with biochemical recurrence of PCa and an initial negative PSMA PET/CT, preliminary findings revealed positive 18F-fluciclovine PET/CT scans in over 54 percent of the cohort, according to a recent poster presentation at the SNMMI conference.
